Tourmaline Bio (TRML) News Today $47.61 +0.01 (+0.02%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$47.51 -0.10 (-0.21%) As of 09/12/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Why Is Tourmaline Bio Up Today?Toggle Visibility of Why Is Tourmaline Bio Up Today?Tourmaline Bio (NASDAQ:TRML) shares are trading modestly higher today amid a mix of strong market interest and subdued analyst sentiment. The stock has seen heightened volume and a notable gap up, counterbalanced by a slew of hold/neutral ratings and concerns around its proposed sale process. Positive Sentiment: Tourmaline Bio saw unusually strong trading volume, reflecting increased investor attention. Tourmaline Bio (NASDAQ:TRML) Sees Strong Trading Volume - Here's What Happened Positive Sentiment: Shares of TRML gapped up on recent trading, prompting questions about whether it remains a buy. Tourmaline Bio (NASDAQ:TRML) Shares Gap Up - Still a Buy? Neutral Sentiment: Tourmaline Bio updated its Executive Severance and Change in Control Plan, amending benefits for key executives. Tourmaline Bio Updates Executive Severance Plan Neutral Sentiment: TRML was highlighted as one of five biotech stocks to consider in MarketBeat’s September 9th screener. Biotech Stocks To Consider - September 9th Neutral Sentiment: Jefferies Financial Group reaffirmed a “hold” rating with a $47.50 price target (down from $64.00). Tourmaline Bio (NASDAQ:TRML) Receives "Hold" Rating from Jefferies Financial Group Neutral Sentiment: Wedbush reiterated a “neutral” rating and set a $48.00 target. Tourmaline Bio (NASDAQ:TRML) Receives Neutral Rating from Wedbush Neutral Sentiment: Guggenheim reaffirmed a “neutral” rating with its target trimmed to $48.00 from $55.00. Tourmaline Bio (NASDAQ:TRML) Receives Neutral Rating from Guggenheim Neutral Sentiment: HC Wainwright downgraded TRML from “buy” to “neutral” and lowered its target to $48.00. Tourmaline Bio (NASDAQ:TRML) Lowered to "Neutral" Rating by HC Wainwright Neutral Sentiment: Chardan Capital reiterated a “neutral” rating, cutting its target to $48.00 from $70.00. Tourmaline Bio's (TRML) Neutral Rating Reiterated at Chardan Capital Neutral Sentiment: Lifesci Capital reaffirmed a “market perform” rating with a $48.00 target. Lifesci Capital Reaffirms "Market Perform" Rating for Tourmaline Bio (NASDAQ:TRML) Negative Sentiment: Piper Sandler downgraded Tourmaline Bio from “overweight” to “hold.” Piper Sandler Downgrades Tourmaline Bio (TRML) Negative Sentiment: Truist Financial cut its target price to $48.00 (from $63.00) while maintaining a “hold” rating. Truist Financial Reaffirms Hold Rating for Tourmaline Bio (NASDAQ:TRML) Negative Sentiment: Guggenheim further downgraded TRML, removing it from its preferred list. Guggenheim Downgrades Tourmaline Bio (TRML) Negative Sentiment: A shareholder investigation led by Kahn Swick & Foti is probing the adequacy of the $48 cash offer in Novartis’s proposed acquisition of Tourmaline Bio. TOURMALINE INVESTOR ALERT by Kahn Swick & Foti, LLC Posted 1+ days agoAI Generated. May Contain Errors. TRML Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Tourmaline Bio (TRML): Assessing Valuation as Market Interest GrowsSeptember 14 at 12:51 PM | finance.yahoo.comTourmaline Bio (NASDAQ:TRML) Receives "Neutral" Rating from Piper SandlerSeptember 13 at 2:26 PM | marketbeat.comTourmaline Bio Updates Executive Severance PlanSeptember 12 at 5:10 PM | tipranks.comTourmaline Bio (NASDAQ:TRML) Sees Strong Trading Volume - Here's What HappenedSeptember 12 at 2:20 PM | marketbeat.comTruist Financial Reaffirms Hold Rating for Tourmaline Bio (NASDAQ:TRML)September 12 at 9:37 AM | marketbeat.comTourmaline Bio (NASDAQ:TRML) Receives Neutral Rating from GuggenheimSeptember 12 at 9:04 AM | marketbeat.comPiper Sandler Downgrades Tourmaline Bio (TRML)September 12 at 8:44 AM | msn.comTourmaline Bio (NASDAQ:TRML) Lowered to "Neutral" Rating by HC WainwrightSeptember 12 at 8:19 AM | marketbeat.comTourmaline Bio's (TRML) Neutral Rating Reiterated at Chardan CapitalSeptember 12 at 8:19 AM | marketbeat.comPiper Sandler Reiterates "Neutral" Rating for Tourmaline Bio (NASDAQ:TRML)September 12 at 2:54 AM | americanbankingnews.comTourmaline Bio (NASDAQ:TRML) Downgraded to "Neutral" Rating by Chardan CapitalSeptember 12 at 2:21 AM | americanbankingnews.comTourmaline Bio (NASDAQ:TRML) Downgraded by Truist Financial to "Hold"September 12 at 2:21 AM | americanbankingnews.comTourmaline Bio (NASDAQ:TRML) Cut to Neutral at HC WainwrightSeptember 12 at 2:21 AM | americanbankingnews.comTOURMALINE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Tourmaline Bio, Inc ...September 11 at 7:12 PM | tmcnet.comTourmaline Bio (NASDAQ:TRML) Receives "Hold" Rating from Jefferies Financial GroupSeptember 11 at 4:21 PM | marketbeat.comLifesci Capital Reaffirms "Market Perform" Rating for Tourmaline Bio (NASDAQ:TRML)September 11 at 4:21 PM | marketbeat.comBiotech Stocks To Consider - September 9thSeptember 11 at 1:00 PM | marketbeat.comTourmaline Bio (NASDAQ:TRML) Shares Gap Up - Still a Buy?September 11 at 11:13 AM | marketbeat.comTOURMALINE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Tourmaline Bio, Inc. - TRMLSeptember 11 at 10:43 AM | businesswire.comTourmaline Bio (NASDAQ:TRML) Receives Neutral Rating from WedbushSeptember 11 at 8:37 AM | marketbeat.comGuggenheim Downgrades Tourmaline Bio (TRML)September 11 at 6:38 AM | msn.comOctagon Capital Advisors LP Invests $13.77 Million in Tourmaline Bio, Inc. $TRMLSeptember 11 at 6:03 AM | marketbeat.comTourmaline Bio's (TRML) Neutral Rating Reaffirmed at GuggenheimSeptember 11 at 4:14 AM | americanbankingnews.comTourmaline Bio (NASDAQ:TRML) Receives "Market Perform" Rating from Lifesci CapitalSeptember 11 at 2:36 AM | americanbankingnews.comTourmaline Bio (NASDAQ:TRML) Downgraded to Neutral Rating by WedbushSeptember 11 at 2:36 AM | americanbankingnews.comJefferies Financial Group Reiterates Hold Rating for Tourmaline Bio (NASDAQ:TRML)September 11 at 2:36 AM | americanbankingnews.comHC Wainwright & Co. Downgrades Tourmaline Bio (TRML)September 10, 2025 | msn.comTourmaline Bio (NASDAQ:TRML) Hits New 52-Week High - Still a Buy?September 10, 2025 | marketbeat.comLifeSci Capital Downgrades Tourmaline Bio (TRML)September 10, 2025 | msn.comAnalysts Set Tourmaline Bio, Inc. (NASDAQ:TRML) Price Target at $50.14September 10, 2025 | americanbankingnews.comThis Small Biotech Stock Is Surging Today. Here's Why.September 9, 2025 | investopedia.comNovartis to acquire Tourmaline Bio for $1.4 billionSeptember 9, 2025 | msn.comNovartis To Expand Heart Drug Portfolio With $1.4 Billion Tourmaline Bio AcquisitionSeptember 9, 2025 | finance.yahoo.comTRML Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Tourmaline Bio, Inc. Is Fair to ShareholdersSeptember 9, 2025 | businesswire.comAdage Capital Partners GP L.L.C. Cuts Stock Holdings in Tourmaline Bio, Inc. $TRMLSeptember 9, 2025 | marketbeat.comShareholder Alert: The Ademi Firm investigates whether Tourmaline Bio, Inc. is obtaining a Fair Price for its Public ShareholdersSeptember 9, 2025 | businesswire.comNovartis Agrees to Buy Tourmaline Bio in $1.4 Billion-Dollar DealSeptember 9, 2025 | wsj.comNovartis to acquire Tourmaline Bio in deal valuing it at $1.4 billionSeptember 9, 2025 | reuters.comNovartis to Acquire Tourmaline Bio for $1.4 Billion, Enhancing Cardiovascular Treatment PortfolioSeptember 9, 2025 | quiverquant.comQTourmaline Bio Enters into Agreement to be Acquired by Novartis AGSeptember 9, 2025 | globenewswire.comNovartis to acquire Tourmaline Bio, complementing cardiovascular pipeline with pacibekitug for the treatment of atherosclerotic cardiovascular disease (ASCVD)September 9, 2025 | globenewswire.comAmerican Century Companies Inc. Acquires 12,661 Shares of Tourmaline Bio, Inc. $TRMLSeptember 8, 2025 | marketbeat.comHsbc Holdings PLC Takes Position in Tourmaline Bio, Inc. $TRMLSeptember 8, 2025 | marketbeat.comTourmaline Bio, Inc. (NASDAQ:TRML) Given Average Rating of "Buy" by AnalystsSeptember 8, 2025 | marketbeat.comTourmaline Bio (NASDAQ:TRML) Trading 7% Higher - What's Next?September 5, 2025 | marketbeat.comJump Financial LLC Makes New Investment in Tourmaline Bio, Inc. $TRMLSeptember 4, 2025 | marketbeat.comNuveen LLC Invests $1.18 Million in Tourmaline Bio, Inc. $TRMLSeptember 3, 2025 | marketbeat.comTourmaline Bio, Inc. $TRML is QVT Financial LP's 7th Largest PositionSeptember 2, 2025 | marketbeat.comVanguard Group Inc. Buys 84,685 Shares of Tourmaline Bio, Inc. $TRMLSeptember 1, 2025 | marketbeat.comTourmaline Bio highlights positive phase 2 pacibekitug dataSeptember 1, 2025 | msn.com Get Tourmaline Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TRML and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TRML Media Mentions By Week TRML Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TRML News Sentiment▼0.180.93▲Average Medical News Sentiment TRML News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TRML Articles This Week▼534▲TRML Articles Average Week Get the Latest News and Ratings for TRML and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Tourmaline Bio and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Centessa Pharmaceuticals News Denali Therapeutics News ImmunityBio News Agios Pharmaceuticals News IDEAYA Biosciences News Ocular Therapeutix News Harmony Biosciences News Disc Medicine News CG Oncology News Recursion Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TRML) was last updated on 9/14/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThe Obscure Korean War Act That Created a $5.39 Billion Passive Income StreamAn obscure Korean War law has just been enacted by the U.S. government... Allowing it to take a heavy hand ...Angel Publishing | SponsoredDo NOT Day Trade (Do THIS instead)Forget day trading (especially in markets like these). Trade OVERNIGHT instead! I've uncovered a shockin...Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tourmaline Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tourmaline Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TRML Stock Alerts